Recall of SYMBIQ

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by HOSPIRA HEALTHCARE CORPORATION.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Event ID
  • Event Risk Class
  • Event Initiated Date
  • Event Country
  • Event Source
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Extra notes in the data
  • Reason
    Hospira received reports of malfunction s205 backup battery failure alarms in some symbiq v3.13 pumps. this error is related to an installation issue with components on some of the power supplier controller (psc) boards. in those cases where components on the psc board were not installed correctly the backup battery (coin cell) discharges and cannot be recharged.


  • Model / Serial
    Model Catalog: 16026 (Lot serial: All Serial Numbers); Model Catalog: 16027 (Lot serial: All Serial Numbers)
  • Product Description
    Symbiq One/Two Channel Infuser
  • Manufacturer


  • Manufacturer Address
  • Manufacturer Parent Company (2017)
  • Source